By employing immunohistochemistry, a small retrospective study found that high levels of dCK protein expression correlated positively with OS in pancreatic cancer patients undergoing adjuvant gemcitabine chemotherapy [21, 24]. Here, DCK is linked to pancreatic neoplasm.